Key result
Cancer therapy is linked to the development of cardiomyopathy and heart failure.
This review discusses the epidemiologic, pathophysiologic, risk factors, and imaging aspects of cancer therapy-related cardiac dysfunction and heart failure.
No takes yet. Share an insight, caveat, or question.
Supports integrated cardio-oncology care; leaves open prospective trials to define optimal evidence-based strategies.
Bloom et al. (2016) studied this question. Cancer therapy is associated with the development of cardiomyopathy and heart failure, necessitating improved evidence-based care for affected patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: